INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Clorox Company - CLX
Pomerantz LLP is investigating potential securities fraud claims against The Clorox Company (NYSE: CLX) on behalf of its investors. This investigation follows Clorox's disclosure of a significant decline in gross margin and a lowered full-year fiscal 2026 gross margin outlook, which led to a nearly 10% drop in its stock price. The firm encourages affected investors to contact them regarding joining a potential class action lawsuit.
Glad® Features Sesame Street's Oscar the Grouch in new Limited-Edition Packaging
Glad® is launching limited-edition trash bag packaging featuring Sesame Street's Oscar the Grouch, starting exclusively at Walmart and expanding to Target and Dollar General in July. This collaboration aims to add humor and personality to everyday chores, building on a previous campaign that featured Oscar in a remix of the "I Love Trash" song. The initiative seeks to bring joy to consumers and create new merchandising opportunities for retailers.
Callahan Advisors LLC Acquires New Position in The Clorox Company $CLX
Callahan Advisors LLC has initiated a new position in The Clorox Company, purchasing 31,564 shares valued at approximately $3.18 million. Despite significant institutional ownership (78.53%), analyst sentiment is cautious, with a "Reduce" consensus rating and an average price target of $103.40. Several firms have recently increased their stakes in Clorox, while others have cut price targets.
Clorox Co. stock outperforms competitors on strong trading day
Clorox Co. (CLX) stock increased by 1.83% to $94.26 on Wednesday, outperforming the broader market which also saw gains. The S&P 500 Index rose by 1.08% and the Dow Jones Industrial Average increased by 1.31%. Despite the strong trading day, Clorox Co. shares remained 30.51% below their 52-week high.
The Procter & Gamble Company stock (US7427181091): focus on latest quarterly results and dividend stability
The Procter & Gamble Company recently released its quarterly results, reaffirming its commitment to shareholder returns and dividend stability, which is a key focus for consumer-staples investors. P&G, a global leader in household and personal care products, relies on a diversified business model, brand building, and operational efficiency to drive revenue and maintain market leadership across its various segments. The company's strategy involves a combination of price increases, product mix improvements, and productivity programs to sustain margins amidst fluctuating costs and competitive dynamics.
Clorox Co. stock (US1890541097): Outlook lifted after solid quarter and fresh analyst moves
Clorox Co. recently raised its full-year guidance after reporting stronger-than-expected quarterly earnings, reflecting confidence in its restructuring and productivity programs. Analyst views are mixed, with Wells Fargo cutting its price target while Jefferies maintained a Buy rating with a reduced target. The consumer staples stock remains a focus for US investors due to its resilient dividend yield and defensive positioning.
The Clorox Company $CLX Shares Acquired by ProShare Advisors LLC
ProShare Advisors LLC increased its stake in The Clorox Company (CLX) by 5.3% in the fourth quarter, holding over 1.3 million shares valued at $137.7 million. While institutional ownership is high, analyst sentiment is cautious, with a "Reduce" consensus rating and a $103.40 price target. Clorox recently beat earnings expectations and reaffirmed its FY2026 guidance, also paying a quarterly dividend equivalent to a 5.4% annualized yield.
Clorox Co. stock (US1890541097): Guidance raised after solid quarter
Clorox Co. recently raised its full-year outlook after reporting better-than-expected quarterly earnings, driven by price increases, cost savings, and an ongoing restructuring program. The company's core business model focuses on branded consumer staples across health and wellness, household, and lifestyle categories, aiming for category leadership and pricing power. This positive performance reinforces management's confidence in their strategy, despite ongoing exposure to commodity cost swings and competitive pressures in the retail sector.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Clorox Company - CLX
Pomerantz LLP is investigating potential securities fraud claims against The Clorox Company (CLX) on behalf of investors. This investigation follows Clorox's announcement of a decrease in gross margin and a lowered full-year fiscal 2026 gross margin outlook due to higher supply chain costs and delayed cost savings. The news led to a notable drop in Clorox's stock price.
Pine-Sol Tests Social-First Scents on TikTok Shop
Pine-Sol is launching four new, limited-edition scents exclusively on TikTok Shop under the alter-ego brand "OMG da Pine" to pilot a social-first approach to new product development. This initiative aims to gauge relevance with younger consumers and use social media as a "learning lab" to identify trending scents faster. The test will allow Pine-Sol to observe which social-inspired scents resonate most with consumers, facilitating rapid testing and scaling of product ideas through social channels.
Clorox Co stock (US18539C2044): Wells Fargo trims target after fresh hold call
Wells Fargo has lowered its price target for Clorox Co (CLX) to $95 from $100, while maintaining a Hold/Equal-Weight rating. This revision, made on May 18, 2026, highlights concerns about near-term operating conditions and adds a new catalyst for the consumer staples name, as investors focus on margin pressure, dividends, and defensive demand. Clorox, known for its defensive product portfolio and long-standing dividend record, remains a key stock for U.S. investors interested in stability and consistent cash returns.
Clorox Co. stock (US1890541097): Wells Fargo trims price target as investors reassess defensive household name
Wells Fargo maintained its Equal-Weight rating on Clorox Co. but lowered its price target to $95 from $100 after the company's recent quarterly update. The analyst firm noted Clorox's focus on productivity measures and sustained dividend, amidst normalized demand and ongoing cost pressures. The article details Clorox's core business model, key revenue drivers, and its position as a defensive holding for US investors, emphasizing the importance of dividends and brand equity.
Kimberly-Clark CEO Just Answered the Two Questions Every KMB Investor Is Asking
Kimberly-Clark CEO Mike Hsu addressed key investor concerns regarding the Kenvue acquisition and the company's dividend sustainability at the annual meeting. He framed the Kenvue deal as an extension of the "Powering Care" transformation, emphasizing the shift from lower-growth tissue operations to higher-margin consumer health brands, and reassured shareholders that the dividend payout is sustainable despite elevated non-cash restructuring charges. The article highlights that the stock's future trajectory will largely depend on the regulatory clearance and successful integration of the Kenvue deal.
Wells Fargo Adjusts PT on Clorox Company to $95 From $100, Maintains Equalweight Rating
Wells Fargo has revised its price target for the Clorox Company (CLX) to $95, down from the previous $100. Despite this adjustment, the firm has decided to maintain its Equalweight rating on the stock. This indicates a slightly more cautious outlook on the company's valuation while not suggesting a significant underperformance or outperformance expectation.
CLX Maintained by Wells Fargo -- Price Target Lowered to $95
Wells Fargo maintained an Equal-Weight rating for Clorox (CLX) but lowered its price target to $95 from $100. Despite the cautious analyst sentiment, Clorox is considered undervalued by 32.6% based on GuruFocus's GF Value™, with a current price of $90.64 against an intrinsic value of $134.46. Insider buying activity of $429,100 in the last three months also suggests confidence in the company's future prospects.
Northwestern Mutual Wealth Management Co. Acquires 739,005 Shares of The Clorox Company $CLX
Northwestern Mutual Wealth Management Co. significantly increased its stake in The Clorox Company ($CLX) during the fourth quarter, purchasing an additional 739,005 shares, bringing its total holdings to 749,703 shares valued at approximately $75.6 million. Despite Clorox's recent earnings beat and a strong dividend yield of about 5.5%, analyst sentiment remains cautious with an average "Reduce" rating and a consensus price target of $103.73. Other institutional investors also adjusted their positions, and a director recently purchased 5,000 shares.
Clorox Co. stock (US1890541097): Earnings rebound and cost actions in focus
Clorox Co. recently reported fiscal third-quarter 2025 results showing recovering sales and margins after a 2023 cyber incident, alongside continued efforts in cost savings and brand investments. The company maintains its full-year outlook and emphasizes its core business model rooted in a diverse portfolio of household and lifestyle brands, strategic brand equity, and efficiency in cost management. Future performance will depend on the effectiveness of cost programs, demand trends in key product lines, and the overall economic climate impacting household spending.
Clorox Co. stock (US1890541097): investors watch after latest quarterly update and dividend focus
Clorox Co. has drawn investor attention following its latest quarterly results, which highlighted a continued focus on dividends and cost-saving initiatives. Investors are assessing how moderated demand and pricing strategies will impact the household products manufacturer. The company, known for its diversified consumer staples portfolio, is navigating a post-pandemic environment with a strong emphasis on brand investment and productivity programs.
Q1 2026 Earnings Review: Clorox and Spectrum Brands Results as of May 18, 2026 - News and Statistics
This article reviews the Q1 2026 earnings for Clorox and Spectrum Brands, two prominent household product companies. Clorox reported flat revenue year-over-year but beat EBITDA estimates, while Spectrum Brands saw a 4.9% increase in revenue, surpassing analyst expectations. Despite solid performances from both, their stock prices declined post-earnings.
The Dividend Stock That Keeps Raising Its Payout No Matter What the Market Does
Procter & Gamble (NYSE: PG) is highlighted as a robust dividend stock due to its 70-year history of increasing payouts and strong brand loyalty for its essential consumer products. Despite not being a growth stock, P&G offers stability and a reliable dividend income for investors, especially during economic uncertainty, largely thanks to its dominant market position and substantial marketing budget. Its recent 14% stock pullback presents a potential entry point for income-focused investors.
Pinnacle Associates Ltd. Grows Stock Position in The Clorox Company $CLX
Pinnacle Associates Ltd. significantly increased its stake in The Clorox Company by 134.8% in the fourth quarter, now owning 24,623 shares valued at $2.48 million. Clorox recently reported strong quarterly earnings, beating analyst estimates with $1.64 EPS and $1.67 billion in revenue, and issued FY2026 EPS guidance of $5.45 to $5.65. Despite a 5.5% dividend yield, analysts maintain a cautious "Reduce" rating with a consensus price target of $103.73.
How New Long-Term Debt and Cautious Guidance At Clorox (CLX) Has Changed Its Investment Story
Clorox recently issued US$1.5 billion in fixed-rate bonds and updated its fiscal 2026 EPS guidance to a more cautious US$4.78 to US$4.98, reflecting slower market share recovery and integration efforts. This combination has shifted investor focus towards how Clorox will balance growth investments with balance sheet resilience amidst elevated debt. The company's investment narrative now heavily relies on its ability to overcome slow category growth and pricing pressure, with some analysts noting a more pessimistic outlook than the consensus due to these developments.
Clorox outlines $20M-$25M Q4 oil headwind while integrating $800M GOJO business
Clorox is facing an estimated $20 million to $25 million headwind in its fourth fiscal quarter due to rising oil prices. Despite this, the company is proceeding with the integration of its newly acquired GOJO business, valued at $800 million. This dual challenge highlights the current market pressures and strategic efforts impacting Clorox's financial outlook.
Clorox Co. stock (US1890541097): Dividend, earnings and analyst pressure shape the outlook
Clorox Co. (US1890541097) remains a focus for investors due to its dividend profile, recent earnings reaction, and analyst commentary. Despite lagging the broader market, its defensive cash-flow appeal attracts income investors, though soft share performance and an uncertain operating backdrop create mixed sentiment. Analysts are cautious, with some maintaining a "Sell" rating, indicating a need for more evidence of operating improvement and margin recovery.
Clorox Company (The) Stock 12‑Month Price Target Cut to $100.2, Implies 10% Upside
The average 12-month price target for Clorox Company (The) stock has been lowered to $100.2 from $102 by 15 analysts, implying a 10% potential upside from its May 14 closing price. Despite the target cut, the consensus rating from 21 analysts remains "Hold," with 3 Buys, 13 Holds, and 5 Sells. Investors can find more detailed analyst data and historical recommendations on TradingView's platform.
Clorox outlines $20M-$25M Q4 oil headwind while integrating $800M GOJO business
Clorox is facing a significant $20 million to $25 million headwind in its fourth quarter due to increased oil prices. Concurrently, the company is integrating the recently acquired $800 million GOJO business, which presents both opportunities and challenges. This financial challenge from rising oil costs comes as Clorox navigates the strategic integration of a major acquisition.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Clorox Company - CLX
Pomerantz LLP is investigating potential securities fraud claims against The Clorox Company (NYSE: CLX) on behalf of investors. This investigation follows Clorox's report of a decrease in gross margin and a lowered full-year fiscal 2026 gross margin outlook, attributed to higher supply chain costs and delayed cost savings due to ERP stabilization. Consequently, Clorox's stock price fell significantly after this announcement.
Jim Cramer Says Kimberly-Clark and Kenvue Merger “Will Produce Tremendous Returns”
Jim Cramer expressed optimism about Kimberly-Clark (NASDAQ: KMB), despite recent setbacks like a distribution center fire. He believes that the impending merger with Kenvue will yield significant returns, though he noted the current market might not reward the stock immediately. Cramer also highlighted Kimberly-Clark's over 5% dividend yield and suggested buying more shares, expressing faith in CEO Mike Hsu.
Spotting Winners: Church & Dwight (NYSE:CHD) And Household Products Stocks In Q1
This article analyzes the Q1 performance of Church & Dwight (NYSE:CHD) and other household products stocks. While the household products sector generally reported strong Q1 revenues, share prices have collectively declined by an average of 3.5% since earnings. Church & Dwight beat revenue expectations but presented mixed results, while Spectrum Brands and Central Garden & Pet showed strong performance; Energizer had the weakest showing.
Clorox Co stock (US18539C2044): Household products leader navigates consumer trends
Clorox Co maintains its position as a key player in household essentials, demonstrating resilience with steady demand for brands like Clorox bleach and Glad bags, as evidenced by a 1% sales increase in Q3 fiscal 2026. The company navigates market shifts through brand strength, product innovation, and sustainability efforts, appealing to US investors through its stable consumer staples portfolio. Clorox's strong market share in cleaning products and strategic diversification ensure consistent performance despite competitive pressures.
Clorox Co. stock (US1890541097): Household products leader navigates consumer shifts
Clorox Co. maintains steady operations amid evolving consumer demands, with its stock trading strongly on Nasdaq. The company focuses on brand strength, sustainable innovation, and benefits from defensive exposure in the consumer staples sector, making it appealing for US investors. Q3 2026 net sales reached $1.83 billion, driven by its Lifestyle and Cleaning segments.
Is Wall Street Bullish or Bearish on Clorox Company Stock?
The Clorox Company (CLX) shares have underperformed the broader market and its industry benchmark over the past year, with a significant drop after its Q3 2026 earnings release due to a weak outlook. Analysts currently have a "Hold" consensus on the stock, with 12 out of 18 analysts rating it as such, and one analyst maintaining a "Sell" rating. Despite some upside potential from its mean price target, investor confidence has been negatively impacted by the company's lowered full-year EPS guidance.
A Look at Clorox Co (CLX) After 3.2% Gain -- GF Value $134.46 vs Price $92.00
Clorox Co (CLX) shares rose 3.2% to $92.00, placing its current price significantly below its GF Value™ estimate of $134.46, indicating it is undervalued. The company holds a GF Score™ of 74/100, suggesting above-average quality and long-term potential, primarily driven by strong profitability. Insider buying activity of $0.4M in the last three months, with no selling, further supports confidence in the stock's future prospects.
Clorox CEO and CFO to speak at dbAccess Global Consumer Conference in Paris on June 3
Clorox CEO Linda Rendle and CFO Luc Bellet will participate in a fireside chat at the dbAccess Global Consumer Conference in Paris on June 3. The event will be webcast live on Clorox's website, offering insights into the company's strategy and performance. This engagement follows news that Clorox is facing an investor lawsuit for allegedly misleading financial statements after a decrease in its gross margin and a lowered full-year margin outlook.
Clorox Co. stock (US1890541097): Latest company overview for US investors
Clorox Co. (CLX) maintains its position as a key consumer staples company in the US, known for its cleaning, charcoal, and personal care products. Despite a slight dip in net sales, the company's recent quarterly results beat analyst expectations, driven by strong brand loyalty, innovation, and consistent demand for essential goods. Clorox offers US investors a defensive stock option with a reliable dividend track record and significant market share in critical household categories.
Watch Clorox CEO and CFO in June 3 Paris fireside chat
Clorox (NYSE: CLX) announced that its Chair and CEO Linda Rendle and CFO Luc Bellet will participate in a fireside chat at the dbAccess Global Consumer Conference in Paris on June 3, 2026. A live webcast and replay of the presentation will be available on Clorox's website, starting at 12:00 p.m. CEST (6:00 a.m. ET). This announcement follows recent product innovations, the acquisition of GOJO Industries, and mixed financial updates for the company.
Clorox to Present at dbAccess Global Consumer Conference
The Clorox Company announced that its Chair and CEO, Linda Rendle, and CFO, Luc Bellet, will participate in a fireside chat at the dbAccess Global Consumer Conference in Paris on June 3. A live webcast of the presentation will be available on the company's website, with a replay available afterward. Clorox, headquartered in Oakland, California, is known for its trusted brands including Brita, Burt's Bees, Clorox, and Glad.
Clorox to Present at dbAccess Global Consumer Conference
The Clorox Company announced that its Chair and CEO Linda Rendle and CFO Luc Bellet will participate in a fireside chat at the dbAccess Global Consumer Conference on June 3 in Paris. A live webcast of the presentation will be available on the company's website. Clorox, headquartered in Oakland, California, is known for brands like Brita, Burt's Bees, Clorox, and Glad.
Clorox Co. stock outperforms competitors on strong trading day
Clorox Co. (CLX) stock increased by 3.24% to $92.00, outperforming leading market indexes like the S&P 500 and Dow Jones Industrial Average on a mixed trading day. This marks the second consecutive day of gains for the stock.
Clorox Co. stock (US1890541097): BNP Paribas cuts price target to $97
BNP Paribas has lowered its price target for Clorox Co. stock to $97 from $128, while maintaining a neutral rating. This adjustment, made on May 12, 2026, reflects challenges in the household products market, as the stock traded at $88.90 USD on May 11, down 3.54%. Clorox, known for brands like Clorox bleach and Glad bags, continues to face market headwinds despite its strong brand presence and defensive exposure to consumer staples.
CLX Investors Have Opportunity to Join The Clorox Company Fraud Investigation with the Schall Law Firm
The Schall Law Firm is investigating The Clorox Company (NYSE: CLX) for potential securities law violations after the company's Q3 2026 financial results revealed a decrease in gross margin and a lowered full-year outlook due to supply chain costs and delayed cost savings. This news led to a more than 9.6% drop in Clorox's share price. The firm is encouraging investors who suffered losses to participate in their investigation.
CLX Investors Have Opportunity to Join The Clorox Company Fraud Investigation with the Schall Law Firm
The Schall Law Firm is investigating The Clorox Company (NYSE: CLX) for alleged securities law violations after Clorox reported a decrease in gross margin and lowered its full-year outlook in Q3 2026 financial results. The company attributed these shortfalls to supply chain costs and delayed cost savings, causing its shares to fall over 9.6%. Shareholders who suffered losses are encouraged to participate in the investigation.
Clorox stock (US1890541097): BNP Paribas cuts price target to $97
BNP Paribas has lowered its price target for Clorox stock (US1890541097) to $97 from $128, while maintaining a neutral rating. This adjustment reflects analyst skepticism regarding Clorox's valuation and near-term earnings potential, in a market experiencing volatile conditions and margin pressures. The company, known for its household and professional products, faces challenges with raw material costs and competitive pricing.
Jensen Quality Mid Cap Fund Trimmed Donaldson Company (DCI) For Valuation Reasons
The Jensen Quality Mid Cap Fund reduced its position in Donaldson Company, Inc. (DCI) during Q1 2026, primarily due to valuation concerns. Despite this, Donaldson's shares gained 21.72% over the past 52 weeks. The fund stated its process focuses on high-quality companies with over 15% ROE for ten years.
Jensen Quality Mid Cap Fund Trimmed The Clorox Company (CLX) to Improve Risk-Return Profile
Jensen Quality Mid Cap Fund reduced its position in The Clorox Company (CLX) in Q1 2026 to enhance the portfolio's risk-return profile. The fund, which aims for long-term growth, reported a -2.53% return in Q1 2026, underperforming the MSCI US Mid Cap 450 Index. While 48 hedge funds held CLX at the end of Q4, Jensen believes certain AI stocks offer better upside potential and less downside risk.
BNP Paribas Adjusts Price Target on Clorox Company to $97 From $128, Maintains Neutral Rating
BNP Paribas has reduced its price target for The Clorox Company to $97 from $128, while keeping a "Neutral" rating on the stock. This adjustment reflects a revised outlook from the financial institution on the consumer products company. The report was published on MarketScreener, indicating an updated analyst perspective on Clorox's valuation.
Clorox Co (CLX) Shares Fall 3.5% -- What GF Score of 73 Tells In
Clorox Co (CLX) shares recently fell by 3.5% to $88.90, making the stock appear significantly undervalued according to GuruFocus' GF Value™ of $134.67. The company's GF Score™ of 73 indicates above-average performance, particularly in profitability, despite lower scores in growth and financial strength. Insider buying of $0.4 million over the last three months further suggests confidence in the company's future prospects.
Clorox Raises $1.5 Billion Through Senior Notes Offering
The Clorox Company successfully executed an underwriting agreement to issue $1.5 billion in senior notes across varying maturities in May 2026. This move adds long-term debt capital to its balance sheet, providing fixed-rate funding and supporting financing needs. Although an AI analyst rates Clorox as "Neutral" due to balance-sheet strain and cash-flow trends, the company's improved profitability and moderate P/E with a high dividend yield offer some offset.
Clorox (CLX) sells multiple senior note tranches maturing 2031 to 2036
The Clorox Company has issued new senior notes in three tranches, totaling $1.5 billion, with maturities ranging from 2031 to 2036. The public offering closed on May 11, 2026, under an existing Indenture from 2022. These fixed-rate senior obligations will establish interest costs for Clorox over the next decade, with their impact on overall leverage and interest coverage to be detailed in future financial reports.
Clorox Co. stock underperforms Monday when compared to competitors
Clorox Co. (CLX) shares dropped 3.54% on Monday, closing at $88.90, despite a generally positive trading day for the broader market. This decline broke a three-day winning streak for the company's stock. The S&P 500 Index and the Dow Jones Industrial Average both saw gains of 0.19%.
